iJak-381
Modify Date: 2024-04-09 15:19:30
iJak-381 structure
|
Common Name | iJak-381 | ||
|---|---|---|---|---|
| CAS Number | 1831144-46-7 | Molecular Weight | 612.039 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H28ClF2N9O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of iJak-381iJak-381 (iJak381) is a potent, selective inhalable and lung-restricted inhibitor of JAK1 with IC50 of 8.52 nM, displays 6.3/704/28 fold selectivity over JAK2/JAK3/TYK2; suppresses STAT 6 activation by IL-1, suppresses ovalbumin-induced lung inflammation in both murine and guinea pig asthma models and improved allergen-induced airway hyperresponsiveness in mice; In a model driven by human allergens, iJak-381 had a more potent suppressive effect on neutrophil-driven inflammation compared to systemic corticosteroid administration, reduces lung pathology without affecting systemic Jak1 activity in rodents. |
| Name | iJak-381 |
|---|
| Description | iJak-381 (iJak381) is a potent, selective inhalable and lung-restricted inhibitor of JAK1 with IC50 of 8.52 nM, displays 6.3/704/28 fold selectivity over JAK2/JAK3/TYK2; suppresses STAT 6 activation by IL-1, suppresses ovalbumin-induced lung inflammation in both murine and guinea pig asthma models and improved allergen-induced airway hyperresponsiveness in mice; In a model driven by human allergens, iJak-381 had a more potent suppressive effect on neutrophil-driven inflammation compared to systemic corticosteroid administration, reduces lung pathology without affecting systemic Jak1 activity in rodents. |
|---|---|
| References | References 1. Dengler HS, et al. Sci Transl Med. 2018 Nov 21;10(468). pii: eaao2151. doi: 10.1126/scitranslmed.aao2151. View Related Products by Target JAK |
| Molecular Formula | C28H28ClF2N9O3 |
|---|---|
| Molecular Weight | 612.039 |